›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies

Early stage IT and Healthcare Investing

AkaRx

portfoliocompanies

company snapshot

AkarRx

AkaRx was a biopharmaceutical company formed as a spin-out of the merger of Yamanouchi Pharmaceutical and Fujisawa Health care. AkaRx developed therapeutic treatments that addresses unmet medical needs and provided significant benefits over currently available therapies. The company's lead product, AKR-501, t platelet disorders of diverse etiologies. Eisai Pharamaceuticals acquired AkaRx in 2009.

website
www.eisai.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share